Skip to main content
. 2013 Oct 22;8(10):e79661. doi: 10.1371/journal.pone.0079661

Figure 1. sCD59 Attenuates Leakage of Retinal Vessels in Diabetic Mice.

Figure 1

(a). Quantification of fluorescein leakage from retinal vessels into the vitreous in un-injected diabetic eyes (n=14) showing a 310% increase in leakage 25 minutes following intraperitoneal injection of sodium fluorescein when compared to un-injected non-diabetic eyes (n=8) [p<0.0001] (b-d). Quantification of fluorescein leakage from retinal vessels into the vitreous in un-injected diabetic eyes (n=8) compared to un-injected non-diabetic eyes (n=8) showing no difference in leakage at 5, 15, and 20 minutes following intraperitoneal injection of sodium fluorescein. (e). Quantification of fluorescein leakage from retinal vessels into the vitreous of diabetic eyes pre-injected with AAV2/8-sCD59 (n=16) showing a 60% reduction in leakage when compared to AAV2/8-pA injected control eyes (n=14) [p=0.003]. (f). Quantification of fluorescein leakage from retinal vessels into the vitreous of diabetic eyes pre-injected with AAV2/8-pA injected control eyes (n=14) and Ringer’s lactate (R/L) injected control eyes (n=16) showing no difference in leakage and suggesting that the injection procedure rather than the AAV is responsible for an increase in vascular leakage in injected eyes above that of the un-injected diabetic eyes. RFU, relative fluorescence units. n represents the number of eyes.